Precision Medicine in Type 2 Diabetes Mellitus: Advances in Continuous Assessment, Subclassification, Personalized Therapies, and Disease Remission: A Comprehensive Review.
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Precision medicine in type 2 diabetes mellitus (T2DM) shifts from uniform treatment to individualized strategies addressing genetic, metabolic, environmental, and clinical heterogeneity. Key pillars include continuous glucose monitoring (CGM) for dynamic glycemic insights, subtype stratification (e.g., severe insulin-resistant diabetes [SIRD], severe insulin-deficient diabetes [SIDD]), pharmacogenomics-guided therapy, and interventions enabling remission. CGM improves time in range, reduces variability, and supports tailored adjustments beyond HbA1c limitations. Clustering identifies differential complication risks and drug responses, favoring SGLT2 inhibitors in SIRD or GLP- receptor agonists in SIDD. Remission sustained normoglycemia without medication
Fields of Study & Subjects
Diabetes Treatment and Management
Diabetes Management and Research
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Journal / source
- International journal of research and scientific innovation
- Volume
- 13
- Issue
- 2
- Pages
- 1583–1591
- Publication date
- 1 January 2026
- Language
- EN